• NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11

    Источник: Nasdaq GlobeNewswire / 11 май 2023 12:17:42   America/New_York

    EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal second quarter 2023 ended March 31, 2023 and provide a corporate update on May 11, 2023 at 4:30 PM Eastern Time.

    Conference Call and Webcast Information:

    Thursday, May 11, 2023 – 4:30 PM Eastern Time

    Participant Dial-In:
    888-645-4404 / 862-298-0702

    Live Webcast: 
    Join here.

    Phone Replay:
    877-660-6853 / 201-612-7415, Access ID: 13738525; available through May 25, 2023

    Webcast Replay:        
    Available for 12 months

    About NeuroOne

    NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com.

    Contact:

    800-631-4030
    ir@nmtc1.com


    Primary Logo

Опубликовать